89bio, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 19 rows in 2020. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-12-16: Reporting owner Waisbourd Ram; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2020-11-16: Reporting owner Le-Nguyen Quoc; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2020-11-16: Reporting owner Waisbourd Ram; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2020-06-22: Reporting owner Grunberg Gregory; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-12-16 | Waisbourd Ram Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,000 88,203 owned after | $1.93 exercise price | 2020-12-18 | |
| 2020-11-16 | Le-Nguyen Quoc Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,548 21,938 owned after | $3.11 exercise price | 2020-11-18 | |
| 2020-11-16 | Waisbourd Ram Officer (COO and Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,000 95,203 owned after | $1.93 exercise price | 2020-11-18 | |
| 2020-06-22 | Grunberg Gregory Director, 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,000 7,000 owned after | $24.29 exercise price | 2020-07-14 | |
| 2020-06-22 | Altschuler Steven Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,000 7,000 owned after | $24.29 exercise price | 2020-07-14 | |
| 2020-06-22 | Hayden Michael R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,000 7,000 owned after | $24.29 exercise price | 2020-07-14 | |
| 2020-06-22 | DiRocco Derek Director | 4 | Stock Option (Right to Buy) Derivative · Indirect · See footnote | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,000 7,000 owned after | $24.29 exercise price | 2020-07-14 | |
| 2020-06-22 | Naschitz Anat Director, 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Indirect · See footnote | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,000 7,000 owned after | $24.29 exercise price | 2020-07-14 | |
| 2020-06-12 | Zoth Lota S. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $24.05 exercise price | 2020-06-16 | |
| 2020-04-05 | DiRocco Derek Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,000 7,000 owned after | $21.40 exercise price | 2020-04-07 | |
| 2020-04-05 | Naschitz Anat Director, 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,000 7,000 owned after | $21.40 exercise price | 2020-04-07 | |
| 2020-04-05 | Grunberg Gregory Director, 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,000 7,000 owned after | $21.40 exercise price | 2020-04-07 | |
| 2020-04-05 | Hayden Michael R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,000 7,000 owned after | $21.40 exercise price | 2020-04-07 | |
| 2020-03-23 | Altschuler Steven Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $23.22 exercise price | 2020-03-25 | |
| 2020-02-14 | Waisbourd Ram Officer (COO and Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $32.50 exercise price | 2020-03-16 | |
| 2020-02-14 | Martins Ryan Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +47,500 47,500 owned after | $32.50 exercise price | 2020-02-19 | |
| 2020-02-14 | Le-Nguyen Quoc Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $32.50 exercise price | 2020-02-19 | |
| 2020-02-14 | Mansbach Harry H Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,000 45,000 owned after | $32.50 exercise price | 2020-02-19 | |
| 2020-02-14 | PALEKAR ROHAN Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +170,000 170,000 owned after | $32.50 exercise price | 2020-02-19 |